Search result

6 Results found

	Estudio aleatorizado, controlado con placebo, doble ciego de fase III sobre la eficacia y la seguridad del inhibidor humano C1 recombinante para el tratamiento de ataques agudos en pacientes con angioedema hereditario. A randomized, placebo-controlled, double-blind Phase III study of the efficacy and safety of recombinant human C1 inhibitor for the treatment of acute attacks in patients with hereditary angioedema (HAE).

	Studio multicentrico internazionale di osservazione sulla sicurezza a lungo termine di Infliximab (REMICADE) A multicenter international observational study of the long-term safety of Infliximab (REMICADE)

	Concentrado de inhibidor C1 de esterasas humano y pasteurizado (CE1145) para sujetos con deficiencia congénita de C1-INH y ataques abdominales o faciales agudos del angioedema hereditario. Human pasteurized C1 esterase inhibitor concentrate (CE1145) in subjects with congenital C1-INH deficiency and acute abdominal or facial HAE attacks.

	Monitorage et comparaison des effets hémodynamiques des différents agents halogénés utilisés en anesthésie pédiatrique au moyen d'un dispositif d'écho-doppler .sophagien Monitoring and comparison of the hemodynamic effects of different halogenous anesthetics used in pediatric anesthesia by oesophageal echo-doppler device

	Pharmacogénétique et Pharmacovigilance, Réseaux de Recherche en Pharmacogénétique Pharmacogenetics and Averse drug reactions

	TRIAL RANDOMIZZATO, IN DOPPIO CIECO, CONTROLLATO A LEVOCETIRIZINA, PER LA VALUTAZIONE DELL'EFFICACIA DEL MONTELUKAST NEL TRATTAMENTO DELLA RINOCONGIUNTIVITE ALLERGICA STAGIONALE IN BAMBINI DI ETA' COMRESA TRA I 6 E I 14 ANNI

Results 6 of 6 found

1

Concept and coding by Valentina Rossi, Laboratory of Medical Informatics